Selected research
Industry Research
Gout Drugs Industry Research Report 2026
Market perspective
The global Gout Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gout Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gout Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gout Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gout Drugs include Accord, Apotex, Ipca, KPC, Northstar, PIDI, Synpac-Kingdom, Mylan and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gout Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gout Drugs Market by Company
Accord
Apotex
Ipca
KPC
Northstar
PIDI
Synpac-Kingdom
Mylan
Sun Pharma
Yunnan Phytopharmaceutical
Gout Drugs Segment by Type
Benzbromo Malone
Allopurinol
Febuxostat
Colchicine
Other
Gout Drugs Segment by Application
Acute gout
Chronic gout
Gout Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gout Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gout Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gout Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gout Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gout Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gout Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Benzbromo Malone
- Allopurinol
- Febuxostat
- Colchicine
- Other
Applications
- Acute gout
- Chronic gout
Companies covered
- Accord
- Apotex
- Ipca
- KPC
- Northstar
- PIDI
- Synpac-Kingdom
- Mylan
- Sun Pharma
- Yunnan Phytopharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gout Drugs Market Size (2021-2032)
- 2.2.2 Global Gout Drugs Sales (2021-2032)
- 2.2.3 Global Gout Drugs Market Average Price (2021-2032)
- 2.3 Gout Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Benzbromo Malone
- 2.3.3 Allopurinol
- 2.3.4 Febuxostat
- 2.3.5 Colchicine
- 2.3.6 Other
- 2.4 Gout Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Acute gout
- 2.4.3 Chronic gout
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gout Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gout Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Gout Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Gout Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Gout Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gout Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gout Drugs, Product Type & Application
- 3.8 Global Manufacturers of Gout Drugs, Established Date
- 3.9 Global Gout Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord
- 4.1.1 Accord Company Information
- 4.1.2 Accord Business Overview
- 4.1.3 Accord Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Gout Drugs Product Portfolio
- 4.1.5 Accord Recent Developments
- 4.2 Apotex
- 4.2.1 Apotex Company Information
- 4.2.2 Apotex Business Overview
- 4.2.3 Apotex Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apotex Gout Drugs Product Portfolio
- 4.2.5 Apotex Recent Developments
- 4.3 Ipca
- 4.3.1 Ipca Company Information
- 4.3.2 Ipca Business Overview
- 4.3.3 Ipca Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ipca Gout Drugs Product Portfolio
- 4.3.5 Ipca Recent Developments
- 4.4 KPC
- 4.4.1 KPC Company Information
- 4.4.2 KPC Business Overview
- 4.4.3 KPC Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 KPC Gout Drugs Product Portfolio
- 4.4.5 KPC Recent Developments
- 4.5 Northstar
- 4.5.1 Northstar Company Information
- 4.5.2 Northstar Business Overview
- 4.5.3 Northstar Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Northstar Gout Drugs Product Portfolio
- 4.5.5 Northstar Recent Developments
- 4.6 PIDI
- 4.6.1 PIDI Company Information
- 4.6.2 PIDI Business Overview
- 4.6.3 PIDI Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PIDI Gout Drugs Product Portfolio
- 4.6.5 PIDI Recent Developments
- 4.7 Synpac-Kingdom
- 4.7.1 Synpac-Kingdom Company Information
- 4.7.2 Synpac-Kingdom Business Overview
- 4.7.3 Synpac-Kingdom Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Synpac-Kingdom Gout Drugs Product Portfolio
- 4.7.5 Synpac-Kingdom Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Gout Drugs Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Sun Pharma
- 4.9.1 Sun Pharma Company Information
- 4.9.2 Sun Pharma Business Overview
- 4.9.3 Sun Pharma Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sun Pharma Gout Drugs Product Portfolio
- 4.9.5 Sun Pharma Recent Developments
- 4.10 Yunnan Phytopharmaceutical
- 4.10.1 Yunnan Phytopharmaceutical Company Information
- 4.10.2 Yunnan Phytopharmaceutical Business Overview
- 4.10.3 Yunnan Phytopharmaceutical Gout Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Yunnan Phytopharmaceutical Gout Drugs Product Portfolio
- 4.10.5 Yunnan Phytopharmaceutical Recent Developments
5 Global Gout Drugs Market Scenario by Region
- 5.1 Global Gout Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gout Drugs Sales by Region: 2021-2032
- 5.2.1 Global Gout Drugs Sales by Region: 2021-2026
- 5.2.2 Global Gout Drugs Sales by Region: 2027-2032
- 5.3 Global Gout Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Gout Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Gout Drugs Revenue by Region: 2027-2032
- 5.4 North America Gout Drugs Market Facts & Figures by Country
- 5.4.1 North America Gout Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gout Drugs Sales by Country (2021-2032)
- 5.4.3 North America Gout Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Gout Drugs Market Facts & Figures by Country
- 5.5.1 Europe Gout Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gout Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Gout Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Gout Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gout Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gout Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gout Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gout Drugs Market Facts & Figures by Country
- 5.7.1 South America Gout Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gout Drugs Sales by Country (2021-2032)
- 5.7.3 South America Gout Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Gout Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gout Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gout Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gout Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Gout Drugs Sales by Type (2021-2032)
- 6.1.1 Global Gout Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Gout Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Gout Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Gout Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gout Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Gout Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gout Drugs Sales by Application (2021-2032)
- 7.1.1 Global Gout Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Gout Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Gout Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Gout Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gout Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Gout Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gout Drugs Value Chain Analysis
- 8.1.1 Gout Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gout Drugs Production Mode & Process
- 8.2 Gout Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gout Drugs Distributors
- 8.2.3 Gout Drugs Customers
9 Global Gout Drugs Analyzing Market Dynamics
- 9.1 Gout Drugs Industry Trends
- 9.2 Gout Drugs Industry Drivers
- 9.3 Gout Drugs Industry Opportunities and Challenges
- 9.4 Gout Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst